The Effects of Subconcussive Events on Cognition

NCT ID: NCT03394248

Last Updated: 2022-04-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-01-26

Study Completion Date

2020-03-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine early detection of concussion for those at risk of developing symptoms and to be able to detect subconcussive cerebral impairment, and thus gaining a better understanding of the injury patterns for concussions in Men's and Women's Collegiate sports.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Description of the Research Subjects will be members of NYIT's Collegiate Athletic Teams. Potential subjects will be informed about the proposed study and asked if the athlete is interested in participating. If the athlete agrees, the key investigator will review the study procedures, what is expected of the subject, and complete the informed consent process. Participation will be completely voluntary and will have no impact on the quality of care the subject will receive. Inclusion and exclusion criteria will then be evaluated by the key investigator to determine if the subject is qualified to participate in this study. Following consent and review of inclusion and exclusion criteria, the subject will be assigned a subject identification number in which is intended to maintain confidentiality of the subject's personal health information. The number will be used for the duration of the study and in all analyses. Once enrolled, the subjects will complete a baseline questionnaire\* that will include demographic information and personal history, as well as consent for de-identified information to be shared with a third party, Quadrant Biosciences, for research purposes. The subjects will be evaluated by a series of measurements, ClearEdge, Quadrant Bioscience Salivary Testing, King Devick, and Im PACT, in the preseason, midseason, and postseason, or if they are suspected of a concussion by the athletic trainer or team physician. Visit 1: Baseline Data Collection

* Assessment Tools
* Demographic/Baseline questionnaire\*
* ImPACT
* King-Devick
* ClearEdge New York Institute of Technology Institutional Review Board Approved From 07/18/20 to 07/17/21
* Quadrant Bioscience Salivary Testing
* Quadrant Bioscience Salivary Testing Questionnaire
* Estimated Time: 1.5 hours Visit 2: Mid-Season Collection
* Assessment Tools
* ImPACT
* King-Devick
* ClearEdge
* Quadrant Bioscience Salivary Testing
* Quadrant Bioscience Salivary Testing Questionnaire
* Estimated time: 1 hour Visit 3: Post-season Data Collection
* Assessment Tools
* ImPACT
* King-Devick
* ClearEdge
* Quadrant Bioscience Salivary Testing
* Quadrant Bioscience Salivary Testing Questionnaire
* Estimated time: 1 hr Visit 4: If athlete is suspected to have sustained a concussion by the athletic trainer or team physician, the athlete will come for an additional visit
* Assessment Tools
* ImPACT
* King-Devick
* ClearEdge
* Quadrant Bioscience Salivary Testing
* Quadrant Bioscience Salivary Testing Questionnaire
* Estimated time: 1 hr

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vector Mouthguard

The mouthguard will be used by athletes to measure the magnitude and number of impacts throughout one season.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is at least 18 years age and younger than 50 years of age
* Subject experiences at least 8Gs of force on at least one occasion, as measured by accelerometer

Exclusion Criteria

* The subject suffered from any of the following at the time of event leading to a concussion:

* Loss of consciousness \>2 minutes in the field as reported by witness
* Seizures
* Intractable vomiting
* Paralysis
* The subject has been diagnosed with an underlying neurodegenerative condition that may confound test results (e.g. Parkinson's Disease, Alzheimer's Disease)
* The subject has a current or previous spinal cord injury
* The subject is unable to complete assessment tools
* The subject is pregnant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

New York Institute of Technology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Matthew Heller

Assistant Professor, Family Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthew Heller, D.O

Role: PRINCIPAL_INVESTIGATOR

New York Institute of Technology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York Institute of Technology

Old Westbury, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BHS-1304

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.